Braingaze Launches BGaze Focus: sign up as an exclusive beta tester to gain early access

In this blog, Chandanee Mistry, UK Lead at Braingaze, shares insights into the launch of BGaze Focus, a self-help app designed to help reduce symptoms of ADHD. The app is designed to transform how individuals and families approach home-based solutions. To ensure the product meets the needs of its users, Braingaze is inviting an exclusive group of up to 500 beta testers to try the app during its early stages, starting today, 30 January 2025.

How BGaze Focus is Redefining ADHD Solutions

ADHD affects around 708,000 children in the UK, yet traditional treatment options often fall short. Over 50% of children prescribed medication discontinue its use due to side effects like anxiety, sleep disturbances, or appetite suppression. Meanwhile, non-medication therapies sometimes fail to hold attention, leaving families and individuals without effective, accessible options.

At Braingaze, we’ve developed a tool designed to complement traditional treatments and offer a fresh approach. BGaze Focus makes improving focus and attention an engaging experience, serving as a supportive addition to medication or a stand-alone self-help option for the undiagnosed or those on the waitlist.

The Vision Behind BGaze Focus

BGaze Focus is more than just a game; it’s a digital intervention designed to help individuals and young people improve their focus and attention using only their eyes. Through gaze-based activities like Gaze Slicer and Gaze Surfer, individuals can practice skills that support their cognitive and emotional development at home or in between clinic visits. This innovation is part of a larger mission at Braingaze: to create accessible, impactful tools for addressing neurodevelopmental and cognitive challenges.

But it’s not just about those who use it. BGaze Focus also equips clinicians with the tools they need to track progress and adapt treatments to each patients needs. By combining fun with functionality, we’re creating a solution that benefits both families and healthcare providers.

Join the Exclusive Beta Test Group

As we launch BGaze Focus, we’re inviting up to 500 beta testers to experience the app and provide valuable feedback during its early stages. This exclusive beta test opportunity gives participants early access to a groundbreaking tool designed to make management of symptoms more effective and enjoyable.

Beta testers will have the chance to explore BGaze Focus’s unique features, share their experiences, and shape the development of this innovative digital intervention.

Evidence-Backed Impact

Many studies show that gaze-based digital interventions like BGaze Focus can deliver impressive results for children in particular with ADHD. In our initial study, children using game-based treatments saw a 56% improvement in ADHD symptoms after just three weeks of play.

For families, these outcomes translate into tangible wins, whether it’s sitting still for longer periods or completing homework without frustration.

A Collaborative Approach

BGaze Focus builds on Braingaze’s commitment to leveraging science and technology for meaningful change. Following the success of BGaze Clinic, a diagnostic support tool based on patented eye biomarkers, BGaze Focus represents the next phase of Braingaze’s mission to create impactful, enjoyable solutions for neurodevelopmental challenges.

After receiving support through the DigitalHealth.London Launchpad programme, Braingaze is positioned to scale its impact, offering a cost-effective and engaging complementary solution to traditional therapies or as a lighter touch self-help option that can help address the NHS backlog and support families nationwide.

Shaping the Future of ADHD Care

Working with families and clinicians to launch BGaze Focus has been an inspiring journey. Seeing the difference it makes, both in the lives of young people and adults and in the broader landscape of ADHD care reinforces the potential of combining play and science.

If you’re a parent, teacher, individual with ADHD or clinical professional interested in becoming a beta tester or supporting the initiative, visit our website at www.braingaze.com  or connect with us on LinkedIn. Together, we can create brighter futures for those with ADHD – one focused play at a time.

Braingaze is part of the seventh cohort of the DigitalHealth.London Launchpad programme.

DigitalHealth.London Launchpad is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England and the Mayor of London.

For more information, please visit https://www.gov.uk/government/publications/uk-
shared-prosperity-fund-prospectus.